Analyst Price Target is $170.67
▲ +3.95% Upside Potential
This price target is based on 18 analysts offering 12 month price targets for Johnson & Johnson in the last 3 months. The average price target is $170.67, with a high forecast of $215.00 and a low forecast of $150.00. The average price target represents a 3.95% upside from the last price of $164.18.
Current Consensus is
Moderate Buy
The current consensus among 18 investment analysts is to moderate buy stock in Johnson & Johnson. This rating has held steady since September 2024, when it changed from a Hold consensus rating.
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Read More